First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors
| Image |  |
|---|---|
| Description | scientific article published on 24 January 2020 |
| Author/s |
author: Takeshi Sasaki Yasutaka Tono Mikiya Ishihara Yasuhide Hori |
| Publication date | January 24, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |